Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
P-ENVs
- Development stage
- Preclinical
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
P-ENVs (biomimetic platelet membrane-coated exosome-mimetic nanovesicles) are a novel therapeutic approach designed for the treatment of atherosclerosis. These nanovesicles are derived from mesenchymal stem cells (MSCs) and are coated with a platelet membrane. The biomimetic design aims to enhance targeted delivery to atherosclerotic plaques, addressing challenges associated with large-scale production and organ-specific targeting of traditional MSC-derived exosomes. P-ENVs are being investigated for their targeted efficiency and therapeutic potential in atherosclerosis.
- Other names
- biomimetic platelet membrane-coated exosome-mimetic nanovesiclesplatelet membrane-coated nanovesiclesexosome-mimetic nanovesicles
Beyond the preview
Go deeper on P-ENVs.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on P-ENVs.